Flynn James E
Larimar Therapeutics, Inc. · Director, other* Director by Deputization, 10% Owner
Flynn James E is listed in public filings as director, 10 percent owner, other: * Director by Deputization. This Flynn James E insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Larimar Therapeutics, Inc. (LRMR), Nuvalent, Inc. (NUVL), ARS Pharmaceuticals, Inc. (SPRY), BiomX Inc. (PHGE), and Bicara Therapeutics Inc. Common Stock (BCAX). Investors use Flynn James E's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $35M371.3k shares | SellNov 24, 2025 | $95.45 | -- | |
| $11M3.4M shares | BuyJul 31, 2025 | $3.20 | -- | |
| $11M3.4M shares | BuyJul 31, 2025 | $3.20 | -- | |
| $8.3M2.6M shares | BuyJul 31, 2025 | $3.20 | -- | |
| $6.8M370.1k shares | SellJun 27, 2025 | $18.46 | -- | |
| $170k9.6k shares | SellNov 12, 2024 | $17.77 | -- | |
| $170k9.6k shares | SellNov 12, 2024 | $17.77 | -- | |
| $135k7.9k shares | SellNov 12, 2024 | $17.16 | -- | |
| $135k7.9k shares | SellNov 12, 2024 | $17.16 | -- | |
| $4.1M223.6k shares | SellNov 11, 2024 | $18.15 | -- | |
| $708k40.6k shares | SellNov 11, 2024 | $17.45 | -- | |
| $630k35k shares | BuySep 17, 2024 | $18.00 | -- |